NEUROIMAGING FINDINGS FROM AN EXPERIMENTAL PHARMACOLOGY TRIAL OF NALTREXONE IN HEAVY DRINKERS OF EAST ASIAN DESCENT

BACKGROUND: Despite known genetic variation across races, studies examining pharmacogenetics of a single nucleotide polymorphism (SNP) of the mu-opioid receptor gene (OPRM1) on clinical response to naltrexone have been conducted in predominantly Caucasian samples. Evidence is mixed for pharmacogenet...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drug Alcohol Depend
Autors principals: Lim, Aaron C., Ghahremani, Dara G., Grodin, Erica N., Green, ReJoyce, Bujarski, Spencer, Hartwell, Emily E., Courtney, Kelly E., Hutchison, Kent, Miotto, Karen, Ray, Lara A.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6760244/
https://ncbi.nlm.nih.gov/pubmed/31160146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2019.02.028
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars